Joern Hilfrich

Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial

R. Jakesz, W. Jonat, Michael Gnant et al. · The Lancet · 2005 · 876 citations

Medicine, Endocrinology, Oncology +15

Abstract S3-1: Lapatinib vs Trastuzumab in Combination with Neoadjuvant Anthracycline-Taxane-Based Chemotherapy: Primary Efficacy Endpoint Analysis of the GEPARQUINTO STUDY (GBG 44)

Michael Untch, Sibylle Loibl, Joachim Bischoff et al. · Cancer Research · 2010 · 38 citations

Medicine, Oncology, Pharmacology +17

The role of docetaxel (Taxotere) in neoadjuvant chemotherapy of breast cancer.

Serban Dan Costa, G von Minckwitz, Günther Raab et al. · PubMed · 1999 · 37 citations

Medicine, Oncology, Pharmacology +13

Relationship of omission of adjuvant radiotherapy to outcomes of locoregional control and disease-free survival in patients with or without pCR after neoadjuvant chemotherapy for breast cancer: A meta-analysis on 3481 patients from the Gepar-trials.

David Krug, Bianca Lederer, Jürgen Debus et al. · Journal of Clinical Oncology · 2015 · 14 citations

Medicine, Oncology, Radiation Oncology +17